PHARMACEUTICAL COMPOSITION CONTAINING LK8 PROTEIN AS AN ACTIVE INGREDIENT FOR PREVENTING OR TREATING DIABETIC RETINOPATHY OR AGE-RELATED MACULAR DEGENERATION

摘要

The present invention relates to a pharmaceutical composition containing, as an active ingredient, LK8 protein having an amino acid sequence depicted in sequence identification number 1, for preventing or treating diabetic retinopathy or age-related macular degeneration. The LK8 protein has an effect of inhibiting a bond between fibronectin and vascular endothelial cells, and therefore, can be valuably used as a composition for preventing or treating diabetic retinopathy or age-related macular degeneration.